
Cannapharmarx ( ($CPMD) ) has released a notification of late filing. CannaPharmaRX, Inc. filed Form 12b-25 to notify investors that its Form 10-Q (Quarter Report) for the period ended September
Compare up to 40 stocks
Compared Stocks: 1 / 40

Cannapharmarx ( ($CPMD) ) has released a notification of late filing. CannaPharmaRX, Inc. filed Form 12b-25 to notify investors that its Form 10-Q (Quarter Report) for the period ended September

Cannapharmarx ( ($CPMD) ) has released a notification of late filing. CannaPharmaRX, Inc. has filed a Form 12b-25, notifying investors that its Quarterly Report on Form 10-Q (Quarter Report) for

Cannapharmarx ( ($CPMD) ) has provided an update. On December 12, 2025, CannaPharmaRX announced that the British Columbia Securities Commission revoked the failure-to-file cease trade order imposed on May 11,

Cannapharmarx ( ($CPMD) ) has issued an update. CannaPharmaRX, Inc. has entered into letter agreements with payment schedules to address outstanding debts owed to two significant debtholders. This move aims

Cannapharmarx ( ($CPMD) ) has issued an announcement. CannaPharmaRX has announced strategic developments to enhance its international presence and production capacity, including major shipments to Germany and Portugal, and an

Cannapharmarx ( ($CPMD) ) has issued an announcement. CannaPharmaRX has successfully completed shipments of cannabis to Israel and Germany, with plans for further shipments to Germany. The company is enhancing

Cannapharmarx ( ($CPMD) ) just unveiled an update. Cannapharmarx has appointed Constantine Nkafu as the interim CEO, who has been managing the company’s operations for several months. Nkafu, who also

Cannapharmarx (CPMD) has released an update. CannaPharmaRX is making significant strides in cannabis production with its advanced facility in Alberta, boosting its monthly output and revenue potential. The company’s competitive

Cannapharmarx (CPMD) has released an update. CannaPharmaRx, an emerging power in the cannabis production industry, has successfully completed its initial series of cannabis harvests with products soon to be distributed

Cannapharmarx (CPMD) has released an update. CannaPharmaRx is poised for robust growth in 2023 following a foundational year of strategic progress, including securing a long-term facility lease, acquiring key cannabis
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| May 25, 2027TBA | $1.42M | ― | ― | -0.05 | -0.14 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.